Skip to content

Open Vs. Endoscopic Transversus Abdominis Release Trial

Comparison of Open and Endoscopic Transversus Abdominis Release for Midline Incisional Ventral Hernia - a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06195332
Enrollment
36
Registered
2024-01-08
Start date
2024-10-15
Completion date
2025-12-31
Last updated
2024-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incisional Hernia of Midline of Abdomen

Keywords

incisional hernia, eTEP, open TAR, endoscopic TAR, transversus abdominis release

Brief summary

This study aims to comparatively evaluate the early and long-term results of open and endoscopic TAR procedure for large midline incisional ventral hernias.

Detailed description

Minimally invasive (endoscopic) transversus abdominis release (TAR) - new technique for the treatment of patients with large incisional ventral hernia. Term endoscopic TAR combines two minimally invasive (laparosopic or extraperitoneal (eTEP) approaches. These techniques have demonstrated significant advantages compared with open TAR in several retrospective studies. There are currently no randomized trials comparing open and endoscopic TAR operations for incisional ventral hernia repair.This study aims to comparatively evaluate the early and long-term results of open and endoscopic TAR procedure for large midline incisional ventral hernias. The sample size was determined based on a previously conducted retrospective pilot study comparing the results of open and endoscopic TAR procedures for midline incisional ventral hernia repair. The retrospective study included 133 patients with midline incisional ventral hernias who were underwent Rives-Stoppa hernia repair in combination with bilateral posterior component separation with transversus abdominis release via open (open TAR) or endoscopic (eTAR) technique in Moscow City Hospital №1 from January 2018 to December 2022. All patients were included in the study, starting from the moment of endoscopic TAR technique was introduced into the clinic. At the same time, the learning curve for the open TAR had already been reached at that time; more than 20 open TAR interventions were performed in the clinic in 2016-2017. The average hospitalization time in open TAR group was 6.7 ± 2.14 days. In endoscopic TAR group the average hospitalization time after surgery was 5.2 ± 1.65 bed days. After achieving the learning curve (20 operations) for the endoscopic TAR procedure technique average hospitalization period after surgery was 4.8 ± 1.47 days. Thus, a decrease in the duration of hospitalization in endoscopic TAR group after reaching the learning curve was noted by 28.4%. This fact, based on a retrospective pilot study, allows the investigators to assume as a hypothesis for this RCT a reduction in the duration of hospitalization during endoscopic TAR by at least 30% as a guideline for calculating the power of the study. Thus, assuming a Type I error probability α of 0.05 and a Type 2 error probability β of 0.20, it would require a total sample size of 36 patients (18 patients in each group).

Interventions

PROCEDUREopen TAR

Participants will undergo open TAR repair according to the assigned treatment arm.

PROCEDUREendoscopic TAR

Participants will undergo endoscopic TAR repair according to the assigned treatment arm.

Sponsors

Pirogov Russian National Research Medical University
CollaboratorOTHER
City Clinical Hospital No.1 named after N.I. Pirogov
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* midline incisional hernia * defect width from 8 till 12 cm * ASA I-III class * able to give informed consent * elective hernia repair * considered eligible for minimally invasive ventral hernia repair

Exclusion criteria

* primary ventral hernia * lateral hernia with/without midline * refuse to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
length of stay after surgery30 days after surgeryFrom date of operation until discharge

Secondary

MeasureTime frameDescription
surgical site occurrences rate30 days after surgeryincidence of all type of wound complications
surgical site infection rate30 days after surgeryincidence of wound infection
duration of operationperiod of operationtime from beginning to the end of surgery
rate of postoperative complications Clavien 3a and higher30 days after surgerynumber of participants with postoperative complications Clavien 3a and higher, evaluated by Clavien-Dindo classification of surgical complications from Dindo et al.
Comprehensive complication index30 days after surgeryComprehensive complication index will be calculated after verification of all complications and their classification according to Clavien, evaluated by Clavien-Dindo classification of surgical complications from Dindo et al. Minimum (0 points) - best results, maximum (100 points) - worst result (patient death)
rate of postoperative complications30 days after surgerynumber of participants with postoperative complications

Countries

Russia

Contacts

Primary ContactAlexander Sazhin, professor
sazhin-av@yandex.ru+79163904180
Backup ContactGeorgy Ivakhov, professor
+79262844224

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026